Jamie Ross, fund manager of Henderson EuroTrust, explains the rationale behind the inclusion of the Danish pharmaceutical company Novo Nordisk in his portfolio.
Janus HendersonHenderson EuroTrust plc
About This Trust
- Very experienced management team with a deep understanding of developed European markets
- High conviction rate means the team avoids holdings of less than 1% of the portfolio
- Provides a diversifier to UK- or US-biased equity portfolios
Jamie Ross, CFA
Industry since 2007. Joined Firm in 2007.
Uncovering the best European stocks with Jamie Ross
James Faulkner, editor of Master Investor Magazine, is joined by Jamie Ross, manager of Henderson EuroTrust to talk about why Europe is such an unloved destination for investors right now and why that’s throwing up some very interesting opportunities.
For UK investors. Capital at risk. For a full glossary of terms mentioned within this episode please visit www.janushenderson.com/ukpi/content/glossary.